Episode Details

Back to Episodes

Sept. 12, 2024: What’s next for MDMA after FDA rejection? Interpreting a lost Euripidean find

Published 1 year, 8 months ago
Description
Researchers hoped the FDA would approve the drug commonly known as "ecstasy" to help treat PTSD. But now that the FDA has rejected it in a surprise decision, what's next for the psychedelic? Then, two CU Boulder scholars interpret what they believe to be previously unknown fragments of two lost tragedies by the Greek playwright Euripides. And, using mammograms to increase awareness of dense breast tissue.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us